Text Size

The World Health Organization estimates that over 650 million people worldwide are affected by some form of liver disease. With a shortfall of donors, artificial livers offer an alternative.

60 State St., Suite 700, Boston, MA, 02109, USA

Based in Boston, Massachusetts, HepaLife Technologies Inc.™, is developing a cell-based bioartificial liver system called HepaMate™, as a potentially lifesaving treatment for liver failure patients. The HepaMate™ is designed to combine blood detoxification with liver cell therapy to provide whole liver function in patients with the most severe forms of liver failure. A patented live ...
Read More...

ManufacturerHepalife
Hits1130
Updated27 February 2010
Sign in with Facebook

Fitness Monitoring